CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis

Europe • Euronext Oslo • OSL:CONTX • SE0014731154

3.7 NOK
-0.06 (-1.6%)
Last: Feb 5, 2026, 03:57 PM
Fundamental Rating

5

Overall CONTX gets a fundamental rating of 5 out of 10. We evaluated CONTX against 12 industry peers in the Health Care Technology industry. While CONTX has a great profitability rating, there are some minor concerns on its financial health. CONTX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CONTX was profitable.
  • CONTX had a positive operating cash flow in the past year.
  • Of the past 5 years CONTX 4 years were profitable.
  • Each year in the past 5 years CONTX had a positive operating cash flow.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

  • CONTX has a Return On Assets (3.07%) which is comparable to the rest of the industry.
  • CONTX has a Return On Equity of 3.95%. This is comparable to the rest of the industry: CONTX outperforms 50.00% of its industry peers.
  • CONTX has a Return On Invested Capital (2.67%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CONTX is significantly above the industry average of 8.64%.
  • The last Return On Invested Capital (2.67%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROIC 2.67%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

  • The Profit Margin of CONTX (3.17%) is comparable to the rest of the industry.
  • CONTX's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 2.90%, CONTX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CONTX has grown nicely.
  • CONTX has a Gross Margin of 97.62%. This is amongst the best in the industry. CONTX outperforms 91.67% of its industry peers.
  • CONTX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • CONTX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for CONTX remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
  • CONTX has a worse debt/assets ratio than last year.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • The Debt to FCF ratio of CONTX is 5.01, which is a neutral value as it means it would take CONTX, 5.01 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.01, CONTX is in line with its industry, outperforming 58.33% of the companies in the same industry.
  • A Debt/Equity ratio of 0.07 indicates that CONTX is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.07, CONTX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Altman-Z N/A
ROIC/WACC0.38
WACC7.07%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • CONTX has a Current Ratio of 4.79. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • CONTX has a Current ratio of 4.79. This is amongst the best in the industry. CONTX outperforms 83.33% of its industry peers.
  • A Quick Ratio of 4.70 indicates that CONTX has no problem at all paying its short term obligations.
  • CONTX's Quick ratio of 4.70 is amongst the best of the industry. CONTX outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.79
Quick Ratio 4.7
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -83.70%.
  • Measured over the past years, CONTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.26% on average per year.
  • Looking at the last year, CONTX shows a very negative growth in Revenue. The Revenue has decreased by -13.08% in the last year.
  • CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%

3.2 Future

  • Based on estimates for the next years, CONTX will show a decrease in Earnings Per Share. The EPS will decrease by -7.44% on average per year.
  • CONTX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.49% yearly.
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y0.49%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 74.00, the valuation of CONTX can be described as expensive.
  • CONTX's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (27.67), we can say CONTX is valued expensively.
  • With a Price/Forward Earnings ratio of 30.30, CONTX can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CONTX.
  • CONTX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 74
Fwd PE 30.3
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • CONTX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CONTX.
Industry RankSector Rank
P/FCF 158.76
EV/EBITDA 18.97
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • CONTX has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as CONTX's earnings are expected to decrease with -7.44% in the coming years.
PEG (NY)N/A
PEG (5Y)2.71
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.20, CONTX pays a better dividend. On top of this CONTX pays more dividend than 83.33% of the companies listed in the same industry.
  • CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

CONTEXTVISION AB

OSL:CONTX (2/5/2026, 3:57:42 PM)

3.7

-0.06 (-1.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap286.27M
Revenue(TTM)112.76M
Net Income(TTM)3.58M
Analysts40
Price Target4.08 (10.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100%
Min EPS beat(2)-100%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.52%
Min Revenue beat(2)-22.13%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)50%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.52%
Valuation
Industry RankSector Rank
PE 74
Fwd PE 30.3
P/S 2.36
P/FCF 158.76
P/OCF 29.9
P/B 2.93
P/tB 3.02
EV/EBITDA 18.97
EPS(TTM)0.05
EY1.35%
EPS(NY)0.12
Fwd EY3.3%
FCF(TTM)0.02
FCFY0.63%
OCF(TTM)0.12
OCFY3.34%
SpS1.57
BVpS1.26
TBVpS1.23
PEG (NY)N/A
PEG (5Y)2.71
Graham Number1.19
Profitability
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROCE 3.38%
ROIC 2.67%
ROICexc 8.83%
ROICexgc 9.67%
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
FCFM 1.48%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Debt/EBITDA 0.55
Cap/Depr 92.01%
Cap/Sales 6.39%
Interest Coverage 250
Cash Conversion 79.95%
Profit Quality 46.76%
Current Ratio 4.79
Quick Ratio 4.7
Altman-Z N/A
F-Score5
WACC7.07%
ROIC/WACC0.38
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y0.49%
EBIT growth 1Y-87.72%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-95.22%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-79.63%
OCF growth 3Y51.49%
OCF growth 5Y5.6%

CONTEXTVISION AB / CONTX.OL FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 2 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


What is the profitability of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 7 / 10.


What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?

The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.


What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -103.45% in the next year.